Cytosorbents (CTSO) Financials: Revenue & Earnings

CTSO price $5.35 +0.50 +10.31%

Ticker
CTSO
Price
$5.35
Change
+0.50 +10.31%
Market cap ?
$16.86M
Beta ?
1.37
Sector
Healthcare
Industry
Medical - Devices

Fair value

CTSO fair value $57.19. Price $5.35. Price is 91% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 12.48M. Growth 4.51%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 11.82% (beta 1.4). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 3.15M. Net debt 22.86M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare CTSO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.90—9.90M
2026-08-06-1.40-0.809.63M9.38M
2026-05-13-0.08-0.068.90M9.35M
2026-03-25-0.09-1.009.23M9.59M
2025-11-13-0.04-1.209.48M10.40M
2025-08-07-0.05-0.079.62M9.23M
2025-05-14-0.02-1.608.73M9.01M
2025-03-13-0.60-1.009.20M10.25M
2024-11-07-0.80-1.209.39M10.18M
2024-08-13-1.60-2.009.89M9.68M
2024-05-09-2.40-2.409.79M9.80M
2024-03-14-2.40-2.808.70M9.28M
2023-11-09-4.20-2.408.81M9.50M
2023-08-01-2.80-2.209.42M11.03M
2023-05-02-0.17-2.539.45M8.74M
2023-03-09-0.20-3.409.40M8.54M
2022-11-03-5.60-3.206.46M8.97M
2022-08-02-5.00-2.678.50M9.58M
2022-05-03-4.20-2.407.92M9.72M
2022-03-08-4.20-2.5110.78M9.68M
2021-11-04-3.00-2.408.90M11.96M
2021-08-03-2.20-0.0311.37M12.27M
2021-05-04-2.00-0.0310.14M14.13M
2021-03-09-0.33-0.8011.96M11.75M
2020-11-04-0.40-0.0910.25M47.46M
2020-08-04-1.57-0.089.52M9.79M
2020-05-05-2.00-0.148.16M11.32M
2020-03-05-2.40-0.176.61M9.91M
2019-11-05-4.20-0.145.73M3.77M
2019-08-06-2.20-0.145.85M7.93M
2019-05-07-3.00-3.604.58M6.23M
2019-03-07-3.40-0.135.47M4.65M
2018-11-06-0.10-0.145.10M8.04M
2018-08-02-3.80-0.135.25M3.64M
2018-05-08-2.00-0.134.43M5.90M
2018-03-08-2.20-0.104.30M3.80M
2017-11-09-1.40-1.403.45M3.82M
2017-08-07-0.04-0.063.04M5.36M
2017-05-08-0.05-0.112.60M5.60M
2017-03-03-3.40-0.102.61M1.63M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-15Chan Phillip P.Buy3.77K$6.0022.64K
2026-09-15Sobel Alan D.Buy100$6.01601
2026-09-15Sobel Alan D.Buy500$6.053.02K
2026-09-15Sobel Alan D.Buy1.90K$6.1211.63K
2026-09-14Capponi VincentBuy273$5.901.61K
2026-09-14Capponi VincentBuy1.80K$6.0710.93K
2026-09-04Chan Phillip P.Buy200.00K$0.3570.00K
2026-06-15MARIANI PETER JBuy100.00K$0.4444.00K
2026-06-15Chan Phillip P.Buy10.33K$0.434.44K
2026-06-12Chan Phillip P.Buy251.14K$0.40100.45K
2025-11-18Chan Phillip P.Buy100.00K$0.6464.00K
2025-08-08Chan Phillip P.Buy105.60K——
2025-08-08Chan Phillip P.Buy136.40K$1.00136.40K
2025-08-08Jones Edward RaymondBuy22.00K$1.0022.00K
2025-08-08BATOR MICHAEL G.Buy44.00K$1.0044.00K
2025-08-08MARIANI PETER JBuy71.50K——
2025-08-08MARIANI PETER JBuy90.00K$1.0090.00K
2025-08-08Kim JinyBuy22.00K$1.0022.00K
2025-08-08Capponi VincentBuy89.10K——
2025-08-08Capponi VincentBuy111.10K$1.00111.10K
2025-08-08Deliargyris EfthymiosBuy70.00K——
2025-08-08Deliargyris EfthymiosBuy95.00K$1.0095.00K
2025-08-08Sobel Alan D.Buy22.00K$1.0022.00K
2025-02-24BATOR MICHAEL G.Buy10.00K$1.1311.30K
2025-02-24BATOR MICHAEL G.Sell15.88K$1.1317.94K
2025-02-24Capponi VincentBuy12.00K$1.1313.56K
2025-02-24Capponi VincentSell12.00K$1.1313.56K
2025-02-24MARIANI PETER JBuy32.62K$1.1336.87K
2025-02-24MARIANI PETER JSell32.62K$1.1336.87K
2025-02-24Chan Phillip P.Buy34.17K$1.1338.61K
2025-02-24Chan Phillip P.Sell34.17K$1.1338.61K
2025-02-24Sobel Alan D.Buy21.95K$1.1324.80K
2025-02-24Sobel Alan D.Sell21.95K$1.1324.80K
2025-01-17BATOR MICHAEL G.Buy15.88K$1.0015.88K
2025-01-17BATOR MICHAEL G.Buy15.88K$1.0015.88K
2025-01-17BATOR MICHAEL G.Buy15.88K$1.0015.88K
2025-01-17BATOR MICHAEL G.Sell15.88K$1.0015.88K
2025-01-17Capponi VincentBuy31.76K$1.0031.76K
2025-01-17Capponi VincentBuy31.76K$1.0031.76K
2025-01-17Capponi VincentBuy31.76K$1.0031.76K
2025-01-17Capponi VincentSell31.76K$1.0031.76K
2025-01-17Deliargyris EfthymiosBuy16.23K$1.0016.23K
2025-01-17Deliargyris EfthymiosBuy16.23K$1.0016.23K
2025-01-17Deliargyris EfthymiosBuy16.23K$1.0016.23K
2025-01-17Deliargyris EfthymiosSell16.23K$1.0016.23K
2025-01-17Sobel Alan D.Buy21.95K$1.0021.95K
2025-01-17Sobel Alan D.Buy21.95K$1.0021.95K
2025-01-17Sobel Alan D.Buy21.95K$1.0021.95K
2025-01-17Sobel Alan D.Sell21.95K$1.0021.95K
2025-01-17Chan Phillip P.Buy90.83K$1.0090.83K
2025-01-17Chan Phillip P.Buy90.83K——
2025-01-17Chan Phillip P.Buy90.83K——
2025-01-17Chan Phillip P.Sell90.83K$1.0090.83K
2025-01-17MARIANI PETER JBuy32.62K$1.0032.62K
2025-01-17MARIANI PETER JBuy32.62K——
2025-01-17MARIANI PETER JBuy32.62K——
2025-01-17MARIANI PETER JSell32.62K$1.0032.62K
2024-12-13MARIANI PETER JBuy20.00K$0.9619.29K
2024-12-12MARIANI PETER JBuy20.00K$0.8917.87K
2024-12-11MARIANI PETER JBuy11.36K$0.8910.10K
2024-10-04Deliargyris EfthymiosBuy100.00K$1.19119.00K
2024-10-04Deliargyris EfthymiosBuy50.00K$1.1959.50K
2024-10-04Capponi VincentBuy100.00K$1.19119.00K
2024-10-04Capponi VincentBuy50.00K$1.1959.50K
2024-08-14MARIANI PETER JBuy175.00K——
2024-08-14MARIANI PETER JBuy215.00K$0.90193.50K
2024-08-14MARIANI PETER JBuy65.00K——
2024-08-14MARIANI PETER JBuy110.00K——
2024-08-14MARIANI PETER JBuy80.00K$0.9072.00K
2024-08-14MARIANI PETER JOther0——
2024-04-02Jones Edward RaymondBuy22.00K$0.9521.01K
2024-04-02Deliargyris EfthymiosBuy61.00K——
2024-04-02Deliargyris EfthymiosBuy86.00K$0.9582.13K
2024-04-02Sobel Alan D.Buy22.00K$0.9521.01K
2024-04-02BLOCH KATHLEEN P.Buy65.00K——
2024-04-02BLOCH KATHLEEN P.Buy87.00K$0.9583.08K
2024-04-02BATOR MICHAEL G.Buy44.00K$0.9542.02K
2024-04-02Capponi VincentBuy81.00K——
2024-04-02Capponi VincentBuy101.00K$0.9596.45K
2024-04-02Kim JinyBuy22.00K$0.9521.01K
2024-04-02Chan Phillip P.Buy96.00K——
2024-04-02Chan Phillip P.Buy124.00K$0.95118.42K
2024-03-29Deliargyris EfthymiosBuy47.09K$0.9544.73K
2024-03-29Capponi VincentBuy48.92K$0.9546.48K
2024-03-29BLOCH KATHLEEN P.Buy49.04K$0.9546.59K
2024-03-29Chan Phillip P.Buy130.00K$0.95123.50K
2023-12-13Sobel Alan D.Buy22.56K$1.3330.00K
2023-12-13Sobel Alan D.Buy7.89K$2.0015.79K
2023-12-13Deliargyris EfthymiosBuy22.56K$1.3330.00K
2023-12-13Deliargyris EfthymiosBuy7.89K$2.0015.79K
2023-12-13Capponi VincentBuy18.80K$1.3325.00K
2023-12-13Capponi VincentBuy6.58K$2.0013.16K
2023-12-13BATOR MICHAEL G.Buy37.59K$1.3350.00K
2023-12-13BATOR MICHAEL G.Buy13.16K$2.0026.31K
2023-12-13Jones Edward RaymondBuy7.52K$1.3310.00K
2023-12-13Jones Edward RaymondBuy2.63K$2.005.26K
2023-12-13BLOCH KATHLEEN P.Buy37.59K$1.3350.00K
2023-12-13BLOCH KATHLEEN P.Buy13.16K$2.0026.31K
2023-12-13Kim JinyBuy7.52K$1.3310.00K
2023-12-13Kim JinyBuy2.63K$2.005.26K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 51, holders +1 vs prior quarter. Ownership 25.69%.

HolderSharesChangeChange %Value
AVENIR CORP5.19M-26.56K-0.51%1.94M
NEUBERGER BERMAN GROUP LLC1.97M285.68K+16.97%740.52K
VANGUARD CAPITAL MANAGEMENT LLC1.91M34.07K+1.81%715.86K
CM MANAGEMENT, LLC1.48M00.00%552.21K
SKYLANDS CAPITAL, LLC1.21M-496.10K-29.05%453.06K
BLACKROCK, INC.627.21K-155.78K-19.90%234.58K
GEODE CAPITAL MANAGEMENT, LLC602.06K-105.20K-14.87%225.24K
SARGENT INVESTMENT GROUP, LLC555.76K5.86K+1.07%207.85K
PATHSTONE HOLDINGS, LLC499.91K-45-0.01%186.97K
VANGUARD FIDUCIARY TRUST CO316.17K2.31K+0.74%118.25K
CIBC BANCORP USA INC.172.65K00.00%64.57K
STATE STREET CORP159.29K00.00%59.58K
OSAIC HOLDINGS, INC.134.84K4.42K+3.39%49.99K
UBS GROUP AG131.02K15.82K+13.73%49.00K
NORTHERN TRUST CORP111.66K19.12K+20.66%41.76K
RAYMOND JAMES FINANCIAL INC107.61K-140-0.13%40.25K
NWF ADVISORY SERVICES INC.104.14K00.00%38.95K
RENAISSANCE TECHNOLOGIES LLC100.02K-700-0.69%37.41K
MORGAN STANLEY91.34K-8.83K-8.82%34.16K
KEY CLIENT FIDUCIARY ADVISORS, LLC78.46K00.00%29.34K
VIRTU FINANCIAL LLC71.51K71.51KNew27.00K
XTX TOPCO LTD54.32K18.75K+52.70%20.31K
JANE STREET GROUP, LLC52.20K52.20KNew19.52K
LPL FINANCIAL LLC50.12K26.93K+116.17%18.74K
STIFEL FINANCIAL CORP48.00K00.00%17.95K

Earnings and financials

Cytosorbents Corporation (CTSO) trades at $5.35, with a market cap of $16.86M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cytosorbents (CTSO) Financials: Revenue & Earnings

CTSO$5.35+0.50 +10.31%

$16.86M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History